Clinical Trials Sponsored by Xun Xu

Total 3917 results

Sun Yat-sen University

Completed

Tumor Budding in Patients With Colorectal Cancer Under Different MMR Status

Rectal Cancer | Tumor Budding

China
Chong Kun Dang Pharmaceutical

Completed

Pharmacokinetics and Safety/Tolerability Profile of CKD-379

Type II Diabetes Mellitus

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers

Chronic Heart Failure

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects

Chronic Hepatitis b

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845

Hypogonadism

Korea, Republic of
Sun Yat-sen University

Completed

PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients.

Gastric Cancer Stage IV | EBV

China
Sun Pharmaceutical Industries Limited

Completed

Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca

Keratoconjunctivitis Sicca | Dry Eye Disease

United States
Sun Yat-sen University

Completed

Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer

Rectal Cancer
Chong Kun Dang Pharmaceutical

Completed

A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions

Type2Diabetes

Korea, Republic of
Sun Yat-sen University

Completed

TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer

Penile Cancer

China
Sun Yat-sen University

Completed

Combined Treatment of Sintilimab, Peg-aspargase Plus Anlotinib in NK/T Cell Lymphoma

Radiotherapy | Sintilimab | Anlotinib | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Early Stage | Peg-aspargase | Phase Two | Open

China
Jun Zhang

Completed

Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer

Advanced Ovarian Cancer

China
Sun Yat-sen University

Active, not recruiting

Effect of Probiotics on Lipid Management

Primary Hypercholesterolemia

China
Sun Yat-sen University

Completed

Effect of Probiotics on Cardiometabolic Health

Cardiometabolic Risk Factors

China
Sun Yat-sen University

Active, not recruiting

Effect of Prebiotics on Blood Glucose Management

Hyperglycemia | Insulin Sensitivity

China
Chong Kun Dang Pharmaceutical

Completed

Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects

Healthy Volunteers

France
Sun Yat-sen University

Active, not recruiting

Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma.

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Active, not recruiting

Evaluation of MBL Around Implants Placed in Crestal or Subcrestal Positions: a RCT

Partial Edentulism | Jaw, Edentulous

China
Sun Yat-sen University

Completed

Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer

Breast Cancer Metastatic

China
Sun Pharmaceutical Industries Limited

Completed

A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010) (reSURFACE 1)

Plaque Psoriasis
Sun Yat-sen University

Completed

Intelligent Evaluation and Supervision of Cataract Surgery

Cataract

China
Sun Pharmaceutical Industries Limited

Withdrawn

A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)

Plaque-type Psoriasis
Sun Yat-sen University

Completed

Visual Function in Pediatric Patients With Posterior Lens Opacities

Congenital Cataract Polar Posterior

China
Sun Yat-sen University

Completed

Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Sun Yat-sen University

Withdrawn

Post-operative Satisfaction With Glaucoma Surgery Trial

Glaucoma

China
Sun Pharmaceutical Industries Limited

Withdrawn

Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis

Blepharoconjunctivitis
Sun Pharmaceutical Industries Limited

Completed

Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers

Ocular Inflammation
Sun Pharmaceutical Industries Limited

Completed

An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca

Keratoconjunctivitis Sicca
Sun Pharmaceutical Industries Limited

Completed

2nd Study to Assess ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery (ISV-305)

Inflammation and Pain Associated With Cataract Surgery

United States
Sun Pharmaceutical Industries Limited

Completed

Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects (ISV-303)

Ocular Inflammation
Sun Pharmaceutical Industries Limited

Completed

Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis (DOUBle)

Blepharitis

United States
Sun Pharmaceutical Industries Limited

Completed

One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™

Metastatic Prostate Cancer
Sun Pharmaceutical Industries Limited

Withdrawn

Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine

Stomatitis | Oral Mucositis
Sun Yat-sen University

Enrolling by invitation

Mutation Detection for VRL

Uveitis | Vitreoretinal Lymphoma

China
Sun Yat-sen University

Withdrawn

Satisfaction After Glaucoma Surgery in Rural China

Glaucoma

China
Sun Yat-sen University

Completed

Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension

Hepatocellular Carcinoma(HCC) | Cirrhotic Portal Hypertension

China
Sun Yat-sen University

Completed

uEXPLORER Total-body PET/CT in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Chong Kun Dang Pharmaceutical

Completed

Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus (DISCOVERY)

Type2 Diabetes

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Study to Investigate the Effect of Food on the PK, PD of CKD-381 in Healthy Volunteers

GERD

Korea, Republic of
Sun Yat-sen University

Completed

The Efficacy and Safety of Thymosin-α1 in Patients With HBV-related ACLF

Liver Failure

China
Sun Yat-sen University

Completed

ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGS

NSCLC

China
Sun Yat-sen University

Completed

Aprepitant Without Steroid in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Colorectal Cancer

Chemotherapy-induced Nausea and Vomiting | Colorectal Cancer

China
Sun Yat-sen University

Completed

Sutures in Orbital Implants in Retinoblastoma Patients

Surgery--Complications | Retinoblastoma Bilateral
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.

Type2 Diabetes Mellitus

Korea, Republic of
Sun Yat-sen University

Completed

Neoadjuvant FOLFOXIRI Chemotherapy Alone for Locally Advanced Rectal Cancer (FORTUNE)

Rectal Cancer

China
Sun Yat-sen University

Completed

A Trial of China Laser and Surgery Study Glaucoma in Rural China

Glaucoma

China
Sun Yat-sen University

Enrolling by invitation

Almonertinib for Advanced NSCLC Patients With Rare Mutations in EGFR

Safety of Almonertinib

China
Sun Yat-sen University

Completed

Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer

Non-small-cell Lung Cancer

China
Sun Yat-sen University

Active, not recruiting

Esthetic and Radiographic Outcomes Following Immediate Implant Placement With Thin or Dehiscence Buccal Bone Wall

Jaw, Edentulous, Partially | Acquired Absence of Single Tooth

China

3

Subscribe